ECSP066933A - Sal de clopidogrel y sus formas polimorfas - Google Patents
Sal de clopidogrel y sus formas polimorfasInfo
- Publication number
- ECSP066933A ECSP066933A EC2006006933A ECSP066933A ECSP066933A EC SP066933 A ECSP066933 A EC SP066933A EC 2006006933 A EC2006006933 A EC 2006006933A EC SP066933 A ECSP066933 A EC SP066933A EC SP066933 A ECSP066933 A EC SP066933A
- Authority
- EC
- Ecuador
- Prior art keywords
- polymorphic forms
- clopidogrel salt
- clopidogrel
- salt
- dihydrothiene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
La invención se refiere a naftaleno-1,5-disulfonato de (+)-(S)-a-(2-clorofenil)-6,7-dihidrotieno[3,2-c]piridina-5(4H)-acetato de metilo, o a una de sus formas polimorfas y/o a uno de sus hidratos y/o a uno de sus solvatos, a composiciones farmacéuticas que los contienen, y al método de su uso para inhibir la agregación plaquetaria.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56379504P | 2004-04-20 | 2004-04-20 | |
PCT/US2005/013279 WO2005103059A1 (en) | 2004-04-20 | 2005-04-18 | Clopidogrel salt and polymorphic forms thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP066933A true ECSP066933A (es) | 2006-12-20 |
Family
ID=34966351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2006006933A ECSP066933A (es) | 2004-04-20 | 2006-10-17 | Sal de clopidogrel y sus formas polimorfas |
Country Status (20)
Country | Link |
---|---|
US (2) | US7652139B2 (es) |
EP (1) | EP1740594A1 (es) |
JP (1) | JP2007533746A (es) |
KR (1) | KR20070012676A (es) |
CN (1) | CN1997647A (es) |
AU (1) | AU2005236046A1 (es) |
BR (1) | BRPI0510008A (es) |
CA (1) | CA2561006A1 (es) |
CR (1) | CR8651A (es) |
EA (1) | EA010829B1 (es) |
EC (1) | ECSP066933A (es) |
IL (1) | IL178216A0 (es) |
MA (1) | MA28510B1 (es) |
MX (1) | MXPA06012128A (es) |
NO (1) | NO20065322L (es) |
NZ (1) | NZ551374A (es) |
TN (1) | TNSN06311A1 (es) |
UA (1) | UA84335C2 (es) |
WO (1) | WO2005103059A1 (es) |
ZA (1) | ZA200608035B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1938319B (zh) * | 2004-04-09 | 2010-05-12 | 韩美药品株式会社 | 结晶氯吡格雷萘磺酸盐或其水合物、其制备方法及含其的药物组合物 |
KR100945062B1 (ko) | 2006-03-22 | 2010-03-05 | 한미약품 주식회사 | 클로피도그렐 1,5-나프탈렌디술폰산염 및 이의 수화물의제조방법 |
CN100396687C (zh) * | 2006-05-26 | 2008-06-25 | 浙江海翔药业股份有限公司 | (+)-(s-)-氯吡格雷硫酸氢盐(i型)的制备方法 |
US20100062066A1 (en) * | 2006-11-14 | 2010-03-11 | Acusphere, Inc | Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration |
EP2107061A1 (en) | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of optically enriched clopidogrel |
WO2012123958A1 (en) | 2011-02-14 | 2012-09-20 | Cadila Healthcare Limited | Highly pure salts of clopidogrel free of genotoxic impurities |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2425983C3 (de) | 1973-06-12 | 1978-09-14 | Toyama Chemical Co. Ltd., Tokio | Sulfonsäuresalze von Acylcholinen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzung |
FR2623810B2 (fr) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
FR2779726B1 (fr) * | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
CA2470479A1 (en) * | 2001-12-18 | 2003-06-26 | Teva Pharmaceutical Industries Ltd. | Polymorphs of clopidogrel hydrogensulfate |
US7074928B2 (en) | 2002-01-11 | 2006-07-11 | Teva Pharmaceutical Industries, Ltd. | Polymorphs of clopidogrel hydrogensulfate |
HUP0200438A3 (en) * | 2002-02-06 | 2003-10-28 | Egis Gyogyszergyar Nyilvanosan | Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them |
SE0201661D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
CZ297472B6 (cs) * | 2002-08-27 | 2006-12-13 | Zentiva, A.S. | Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I |
DE10305984A1 (de) | 2003-02-13 | 2004-09-02 | Helm Ag | Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen |
EP1618111B1 (en) * | 2003-04-25 | 2014-12-24 | Cadila Healthcare Limited | Salts of clopidogrel and process for preparation |
GB0321256D0 (en) | 2003-09-11 | 2003-10-08 | Generics Uk Ltd | Novel crystalline compounds |
GB0325603D0 (en) | 2003-11-03 | 2003-12-10 | Sandoz Ag | Organic compounds |
EA008972B1 (ru) | 2004-01-13 | 2007-10-26 | Зентива А.С. | Новые кристаллические формы гидробромида клопидогреля и способы их получения |
RU2006133842A (ru) | 2004-02-24 | 2008-03-27 | Зигфрид Дженерикс Интерэшнл Аг (Ch) | Фармакологически приемлемые соли клопидогрела |
-
2005
- 2005-04-18 NZ NZ551374A patent/NZ551374A/en unknown
- 2005-04-18 UA UAA200612103A patent/UA84335C2/ru unknown
- 2005-04-18 AU AU2005236046A patent/AU2005236046A1/en not_active Abandoned
- 2005-04-18 CA CA002561006A patent/CA2561006A1/en not_active Abandoned
- 2005-04-18 EA EA200601922A patent/EA010829B1/ru not_active IP Right Cessation
- 2005-04-18 ZA ZA200608035A patent/ZA200608035B/en unknown
- 2005-04-18 MX MXPA06012128A patent/MXPA06012128A/es not_active Application Discontinuation
- 2005-04-18 CN CNA2005800118445A patent/CN1997647A/zh active Pending
- 2005-04-18 JP JP2007509563A patent/JP2007533746A/ja active Pending
- 2005-04-18 WO PCT/US2005/013279 patent/WO2005103059A1/en active Application Filing
- 2005-04-18 BR BRPI0510008-9A patent/BRPI0510008A/pt not_active IP Right Cessation
- 2005-04-18 KR KR1020067021812A patent/KR20070012676A/ko not_active Application Discontinuation
- 2005-04-18 EP EP05737387A patent/EP1740594A1/en not_active Withdrawn
-
2006
- 2006-09-20 IL IL178216A patent/IL178216A0/en unknown
- 2006-09-22 CR CR8651A patent/CR8651A/es not_active Application Discontinuation
- 2006-09-27 TN TNP2006000311A patent/TNSN06311A1/en unknown
- 2006-10-02 MA MA29359A patent/MA28510B1/fr unknown
- 2006-10-17 EC EC2006006933A patent/ECSP066933A/es unknown
- 2006-10-19 US US11/550,865 patent/US7652139B2/en not_active Expired - Fee Related
- 2006-11-20 NO NO20065322A patent/NO20065322L/no not_active Application Discontinuation
-
2010
- 2010-01-26 US US12/693,829 patent/US20100227882A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7652139B2 (en) | 2010-01-26 |
US20100227882A1 (en) | 2010-09-09 |
CR8651A (es) | 2007-08-28 |
BRPI0510008A (pt) | 2007-09-18 |
EA010829B1 (ru) | 2008-12-30 |
US20070088048A1 (en) | 2007-04-19 |
MXPA06012128A (es) | 2007-01-31 |
WO2005103059A1 (en) | 2005-11-03 |
EP1740594A1 (en) | 2007-01-10 |
CA2561006A1 (en) | 2005-11-03 |
MA28510B1 (fr) | 2007-04-03 |
KR20070012676A (ko) | 2007-01-26 |
EA200601922A1 (ru) | 2007-02-27 |
CN1997647A (zh) | 2007-07-11 |
NZ551374A (en) | 2010-08-27 |
ZA200608035B (en) | 2008-07-30 |
NO20065322L (no) | 2006-11-20 |
JP2007533746A (ja) | 2007-11-22 |
UA84335C2 (ru) | 2008-10-10 |
TNSN06311A1 (en) | 2007-12-03 |
AU2005236046A1 (en) | 2005-11-03 |
IL178216A0 (en) | 2006-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP066933A (es) | Sal de clopidogrel y sus formas polimorfas | |
BG108868A (en) | Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds | |
MA28531B1 (fr) | Composition de pyrazolo[3,4-b]pyridine, et son utilisation en tant qu'inhibiteur de pdea4 | |
CO5040084A1 (es) | Forma polimorfa del hidrogenosulfato de clopidogrel | |
PL378372A1 (pl) | Tricykliczne związki jako inhibitory kinaz białkowych do wzmacniania skuteczności środków przeciwnowotworowych i radioterapii | |
NI200800021A (es) | Derivados de n - (arilalquil) - 1h - pirrolopiridin - 2 - carboxamidas, su preparación y su aplicación en terapéutica | |
RS51830B (en) | AZAINDOLES USEFUL AS INHIBITORS OF STRENGTH AND OTHER PROTEIN KINASES | |
CR7820A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos | |
ZA200409862B (en) | Benzofused heteroaryl derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use | |
UY29437A1 (es) | Nuevos antagonistas de cgrp | |
NO20051928D0 (no) | Tieno [3,2-b] pyridin-6-karbonitriler og tieno [2,3-b] pyridin-5-karbonitriler som proteasekinase inhibitorer. | |
HUP0501182A2 (hu) | Metalloproteáz inhibitorként hatásos aza-spiro-alkán-származékok és a vegyületeket tartalmazó gyógyszerkészítmények | |
BR0116531A (pt) | Composição farmacêutica, kit e uso de um composto | |
PT1673347E (pt) | Derivados de dibenzo-azepina e benzo-diazepina substituídos, úteis como inibidores de secretase gama | |
GT200500340A (es) | Derivados de octahidropirrolo [3,4-c] pirrol | |
CR8370A (es) | Metodos y composiciones para inhibicion de selectina | |
CO6270226A2 (es) | Nuevos compuestos espirociclicos como antagonistas de cgrp | |
ECSP066932A (es) | Formas polimórficas de hidrobromuro acetato de metil(+)-(s)- alfa-(2-clorofenil)-6,7-dihidrotieno[3,2-c]piridina-5(4h), hidrobromuro de clopidogrel | |
AU2003206068A1 (en) | Indolyl-urea derivatives of thienopyridines useful as anti-angiogenic agents | |
ECSP034531A (es) | Derivados sustituidos de c-ciclohexilmetilamina | |
AR045326A1 (es) | Derivados de aminoquinolina y su uso como ligandos a3 de adenosina | |
AR116021A1 (es) | Composición farmacéutica que comprende clopidogrel y tegoprazan y uso de los mismos para prepararla | |
IL197887A0 (en) | New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 | |
MX2010001602A (es) | "compuestos de 2-(2-oxoindolin-3-iliden)metil-5-(2-hidroxi-3-morfo lin-4-il-propil)-6,7-dihidro-1h-pirrol[3,2-c]pirridin-4(5h)-ona y su uso como inhibidores de proteína quinasa". | |
DE602004013937D1 (de) | Kombinationspräparate zur verhinderung von schlagand einen atii antagonisten enthalten |